Wed, 7 Oct 2026

November 23, 2022

people moves

Hong Kong-based Immuno Cure BioTech names new CFO

FutureCFO Editors November 23, 2022

Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies,

Recent posts

HKEX launches four ETFs for cross-market indices tracking

Study: Finance professionals concern about AI in hiring processes

How sustainability reporting can drive financial performance

SEON partners with Thailand’s DeeMoney for real-time fraud, AML protection

Swift pushes for cross-border payments

Embedded finance revenue to reach US$617B by 2031

Subscribe